The severity of the allopurinol hypersensitivity syndrome is a reminder that specific criteria must be used to decide which patients should be treated with allopurinol (See Table 4: Reasons to Use Medication to Lower Uric Acid )
Many people who have added these supplements to their daily lives say they feel more energized, focused, and motivated
But what exactly are these medications, how do they work, and what should you know to best support your clients who are using them
To view or add a comment, sign in More evidence that the GLP-1 market is expanding, not just shifting
Richard DiMarchi's group at Indiana generated the academic chemistry that anchors oxyntomodulin-derived co-agonists, the design principles behind GLP-1/glucagon duals, and the peptide-scaffolding approaches that Lilly, Zealand, Boehringer Ingelheim, and others have licensed or built upon